Home New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug
 

Keywords :   


New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug

2013-10-14 06:06:15| Biotech - Topix.net

A New Zealand biotechnology company, CuroNZ, received funding from the US National Multiply Sclerosis Society worth $540,000 to be used in pre-clinical studies.

Tags: multiple firm drug zealand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.11 20213 105S P7905-P
15.11 ()
15.11Mizuno Energy 25.5
15.11
15.112 FIELDOOR 3.0-40.5kg
15.113022500
15.11USJ 2024
15.11 TIME XPRESSO 4
More »